Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cd727aa2b4e6c347aadd94971881d671 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J63-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61Q17-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61Q17-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70 |
filingDate |
1996-03-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4fa3157de6773610aae16192e7ce59df http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_434c96d18db93b066b2357717be1926c |
publicationDate |
1997-09-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
JP-H09241162-A |
titleOfInvention |
Anti-inflammatory agent |
abstract |
(57) [Abstract] [PROBLEMS] To provide an anti-inflammatory agent which has an excellent anti-inflammatory effect and is excellent in usability and safety. SOLUTION: Escinol or a salt thereof is used as an active ingredient. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2002501901-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010057856-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2186523-A1 |
priorityDate |
1996-03-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |